Manufacturers Life Insurance Company, The Stoke Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 13,618 shares of STOK stock, worth $163,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,618

Previous 13,964 2.48%

Holding current value

$163,824

Previous $188,000 11.17%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$12.24 - $15.92 $4,235 - $5,508	-346 Reduced 2.48%	13,618 $167,000
Q2 2024 Aug 14, 2024	BUY	$11.03 - $17.52 $21,993 - $34,934	1,994 Added 16.66%	13,964 $188,000
Q1 2024 May 14, 2024	BUY	$4.12 - $14.17 $222 - $765	54 Added 0.45%	11,970 $161,000
Q3 2023 Nov 15, 2023	SELL	$3.78 - $11.99 $133,641 - $423,906	-35,355 Reduced 74.79%	11,916 $46,000
Q2 2023 Aug 11, 2023	BUY	$7.93 - $13.82 $16,803 - $29,284	2,119 Added 4.69%	47,271 $502,000
Q4 2022 Aug 11, 2023	SELL	$7.07 - $15.69 $233 - $517	-33 Reduced 0.07%	45,152 $416,000
Q4 2022 Feb 13, 2023	SELL	$7.07 - $15.69 $233 - $517	-33 Reduced 0.07%	45,152 $416,000
Q3 2022 Aug 11, 2023	SELL	$12.56 - $22.53 $4,320 - $7,750	-344 Reduced 0.76%	45,185 $580,000
Q3 2022 Nov 03, 2022	SELL	$12.56 - $22.53 $4,320 - $7,750	-344 Reduced 0.76%	45,185 $587,000
Q2 2022 Aug 11, 2023	BUY	$10.36 - $23.93 $114,270 - $263,947	11,030 Added 31.97%	45,529 $601,000
Q2 2022 Aug 15, 2022	BUY	$10.36 - $23.93 $114,270 - $263,947	11,030 Added 31.97%	45,529 $603,000
Q1 2022 Aug 11, 2023	SELL	$17.19 - $26.1 $183,125 - $278,043	-10,653 Reduced 23.59%	34,499 $726,000
Q1 2022 May 20, 2022	BUY	$17.19 - $26.1 $405,649 - $615,907	23,598 Added 216.48%	34,499 $755,000
Q4 2021 Feb 16, 2022	BUY	$18.11 - $30.72 $3,947 - $6,696	218 Added 2.04%	10,901 $262,000
Q3 2021 Nov 12, 2021	SELL	$23.65 - $34.44 $17,903 - $26,071	-757 Reduced 6.62%	10,683 $272,000
Q2 2021 Aug 12, 2021	BUY	$30.53 - $41.09 $99,039 - $133,295	3,244 Added 39.58%	11,440 $385,000
Q1 2021 May 03, 2021	BUY	$36.08 - $69.81 $10,824 - $20,943	300 Added 3.8%	8,196 $318,000
Q4 2020 Feb 12, 2021	BUY	$33.62 - $61.93 $9,279 - $17,092	276 Added 3.62%	7,896 $489,000
Q3 2020 Nov 09, 2020	BUY	$22.23 - $37.48 $169,392 - $285,597	7,620 New	7,620 $255,000
Q2 2020 Aug 10, 2020	SELL	$20.26 - $29.73 $214,816 - $315,227	-10,603 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$16.8 - $34.15 $178,130 - $362,092	10,603 New	10,603 $243,000

Others Institutions Holding STOK

# of Institutions

123

Shares Held

57.6M

Call Options Held

9.3K

Put Options Held

35.2K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $474M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Stoke Therapeutics, Inc. Transaction History